Literature DB >> 29090327

Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part II): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.

Stephen M Pastores1, Djillali Annane2, Bram Rochwerg3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29090327     DOI： 10.1007/s00134-017-4951-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

Review 1.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

Authors:  D Paparella; T M Yau; E Young
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Prognostic value of relative adrenal insufficiency after out-of-hospital cardiac arrest.

Authors:  Frédéric Pene; Hervé Hyvernat; Vincent Mallet; Alain Cariou; Pierre Carli; Christian Spaulding; Marie-Annick Dugue; Jean-Paul Mira
Journal:  Intensive Care Med       Date:  2005-04-19       Impact factor: 17.440

Review 4.  Corticosteroids as adjunctive therapy in the treatment of influenza.

Authors:  Chamira Rodrigo; Jo Leonardi-Bee; Jonathan Nguyen-Van-Tam; Wei Shen Lim
Journal:  Cochrane Database Syst Rev       Date:  2016-03-07

Review 5.  Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.

Authors:  Reed A C Siemieniuk; Maureen O Meade; Pablo Alonso-Coello; Matthias Briel; Nathan Evaniew; Manya Prasad; Paul E Alexander; Yutong Fei; Per O Vandvik; Mark Loeb; Gordon H Guyatt
Journal:  Ann Intern Med       Date:  2015-10-06       Impact factor: 25.391

6.  Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial.

Authors:  Spyros D Mentzelopoulos; Sotirios Malachias; Christos Chamos; Demetrios Konstantopoulos; Theodora Ntaidou; Androula Papastylianou; Iosifinia Kolliantzaki; Maria Theodoridi; Helen Ischaki; Dimosthemis Makris; Epaminondas Zakynthinos; Elias Zintzaras; Sotirios Sourlas; Stavros Aloizos; Spyros G Zakynthinos
Journal:  JAMA       Date:  2013-07-17       Impact factor: 56.272

Review 7.  Corticosteroids for acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Peter McIntyre; Kameshwar Prasad; Diederik van de Beek
Journal:  Cochrane Database Syst Rev       Date:  2015-09-12

8.  Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.

Authors:  Spyros D Mentzelopoulos; Spyros G Zakynthinos; Maria Tzoufi; Nikos Katsios; Androula Papastylianou; Sotiria Gkisioti; Anastasios Stathopoulos; Androniki Kollintza; Elissavet Stamataki; Charis Roussos
Journal:  Arch Intern Med       Date:  2009-01-12

9.  Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial.

Authors:  Jan M Dieleman; Arno P Nierich; Peter M Rosseel; Joost M van der Maaten; Jan Hofland; Jan C Diephuis; Ronald M Schepp; Christa Boer; Karel G Moons; Lex A van Herwerden; Jan G Tijssen; Sandra C Numan; Cor J Kalkman; Diederik van Dijk
Journal:  JAMA       Date:  2012-11-07       Impact factor: 56.272

10.  The effect of hydrocortisone on the outcome of out-of-hospital cardiac arrest patients: a pilot study.

Authors:  Min-Shan Tsai; Chien-Hua Huang; Wei-Tien Chang; Wen-Jone Chen; Chiung-Yuan Hsu; Cheng-Chun Hsieh; Chih-Wei Yang; Wen-Chu Chiang; Matthew Huei-Ming Ma; Shyr-Chyr Chen
Journal:  Am J Emerg Med       Date:  2007-03       Impact factor: 2.469
View more
  12 in total

1.  Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.

Authors:  Paul E Verweij; Bart J A Rijnders; Roger J M Brüggemann; Elie Azoulay; Matteo Bassetti; Stijn Blot; Thierry Calandra; Cornelius J Clancy; Oliver A Cornely; Tom Chiller; Pieter Depuydt; Daniele Roberto Giacobbe; Nico A F Janssen; Bart-Jan Kullberg; Katrien Lagrou; Cornelia Lass-Flörl; Russell E Lewis; Peter Wei-Lun Liu; Olivier Lortholary; Johan Maertens; Ignacio Martin-Loeches; M Hong Nguyen; Thomas F Patterson; Thomas R Rogers; Jeroen A Schouten; Isabel Spriet; Lore Vanderbeke; Joost Wauters; Frank L van de Veerdonk
Journal:  Intensive Care Med       Date:  2020-06-22       Impact factor: 17.440

2.  Impact and Beneficial Critical Points of Clinical Outcome in Corticosteroid Management of Adult Patients With Sepsis: Meta-Analysis and GRADE Assessment.

Authors:  Lu-Lu Lin; Hui-Yun Gu; Jie Luo; Long Wang; Chao Zhang; Yu-Ming Niu; Hong-Xia Zuo
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

3.  The Impact of Covid-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis.

Authors:  Ali S Alzahrani; Noha Mukhtar; Abeer Aljomaiah; Hadeel Aljamei; Abdulmohsen Bakhsh; Nada Alsudani; Tarek Elsayed; Nahlah Alrashidi; Roqayh Fadel; Eman Alqahtani; Hussein Raef; Muhammad Imran Butt; Othman Sulaiman
Journal:  Endocr Pract       Date:  2020-12-15       Impact factor: 3.443

Review 4.  Glucocorticoid-Induced Leucine Zipper: A Promising Marker for Monitoring and Treating Sepsis.

Authors:  Ya-Jun He; Ji-Qian Xu; Miao-Miao Sun; Xiang-Zhi Fang; Zhe-Kang Peng; Shang-Wen Pan; Ting Zhou; Ya-Xin Wang; You Shang
Journal:  Front Immunol       Date:  2020-12-16       Impact factor: 7.561

5.  Low-dose corticosteroid therapy for cardiogenic shock in adults (COCCA): study protocol for a randomized controlled trial.

Authors:  Armand Mekontso Dessap; François Bagate; Clément Delmas; Tristan Morichau-Beauchant; Bernard Cholley; Alain Cariou; Benoit Lattuca; Mouhamed Moussa; Nicolas Mongardon; Damien Fard; Matthieu Schmidt; Adrien Bouglé; Mathieu Kerneis; Emmanuel Vivier; François Roubille; Matthieu Duprey; Véronique Decalf; Thibaud Genet; Messaouda Merzoug; Etienne Audureau; Pierre Squara
Journal:  Trials       Date:  2022-01-03       Impact factor: 2.279

6.  Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model.

Authors:  Judy D Day; Soojin Park; Benjamin L Ranard; Harinder Singh; Carson C Chow; Yoram Vodovotz
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

7.  Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial.

Authors:  Karim Asehnoune; Charlene Le Moal; Gilles Lebuffe; Marguerite Le Penndu; Nolwen Chatel Josse; Matthieu Boisson; Thomas Lescot; Marion Faucher; Samir Jaber; Thomas Godet; Marc Leone; Cyrus Motamed; Jean Stephane David; Raphael Cinotti; Younes El Amine; Darius Liutkus; Matthias Garot; Antoine Marc; Anne Le Corre; Alexandre Thomasseau; Alexandra Jobert; Laurent Flet; Fanny Feuillet; Morgane Pere; Emmanuel Futier; Antoine Roquilly
Journal:  BMJ       Date:  2021-06-02

8.  Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass.

Authors:  D Pasero; A M Berton; G Motta; R Raffaldi; G Fornaro; A Costamagna; A Toscano; C Filippini; G Mengozzi; N Prencipe; M Zavattaro; F Settanni; E Ghigo; L Brazzi; A S Benso
Journal:  J Endocrinol Invest       Date:  2020-11-27       Impact factor: 4.256

9.  Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.

Authors:  Chaomin Wu; Dongni Hou; Chunling Du; Yanping Cai; Junhua Zheng; Jie Xu; Xiaoyan Chen; Cuicui Chen; Xianglin Hu; Yuye Zhang; Juan Song; Lu Wang; Yen-Cheng Chao; Yun Feng; Weining Xiong; Dechang Chen; Ming Zhong; Jie Hu; Jinjun Jiang; Chunxue Bai; Xin Zhou; Jinfu Xu; Yuanlin Song; Fengyun Gong
Journal:  Crit Care       Date:  2020-11-10       Impact factor: 9.097

Review 10.  What we have to know about corticosteroids use during Sars-Cov-2 infection.

Authors:  F Ferraù; F Ceccato; S Cannavò; C Scaroni
Journal:  J Endocrinol Invest       Date:  2020-08-28       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.